Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M1 muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine

被引:38
作者
Allman, K [1 ]
Page, KM [1 ]
Curtis, CAM [1 ]
Hulme, EC [1 ]
机构
[1] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England
关键词
D O I
10.1124/mol.58.1.175
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The exofacial part of transmembrane domain 5 (TMD 5) of the cationic amine-binding subclass of 7-transmembrane receptors is thought to be important in binding the side chain of the agonist. Residues Ile-188 through Ala-196 in TMD 5 of the M-1 muscarinic acetylcholine receptor (mAChR) have been studied by Cys- and Ala-scanning mutagenesis. The results are consistent with a helical conformation for this sequence. The positively charged sulfhydryl reagent N-trimethyl-2-aminoethyl methanethiosulfonate reacted selectively with Phe-190 --> Cys, Thr-192 --> Cys, and Ala-193 --> Cys, indicating that the face of TMD 5 accessible from the binding site crevice is consistent with a recent model by Baldwin and colleagues of the transmembrane domain of the 7-transmembrane receptors. In contrast, the acetylcholine derivative bromoacetylcholine reacted selectively with Thr-192 --> Cys, which forms the focus of a group of amino acids (Ile-188, Thr-189, Thr-192, Ala-196) whose mutation decreased the binding affinity of the transmitter ACh itself. The center of this patch of residues is offset to one side of the binding pocket, suggesting that a rotation of TMD 5, relative to that implied by the Baldwin model, may be necessary to optimize the anchoring of acetylcholine within the binding site of the M-1 mAChR. An induced rotation of TMD 5 could contribute to the formation of the activated state of the receptor.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 40 条
[1]  
Allman K., 1997, Life Sciences, V60, P1177, DOI 10.1016/S0024-3205(97)84326-3
[2]   An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors [J].
Baldwin, JM ;
Schertler, GFX ;
Unger, VM .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (01) :144-164
[3]  
Ballesteros J.A., 1995, Methods in Neurosciences, V25, P366, DOI [DOI 10.1016/S1043-9471(05)80049-7, 10.1016/S1043-9471(05)80049-7]
[4]   Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine(6) receptor [J].
Boess, FG ;
Monsma, FJ ;
Meyer, V ;
Zwingelstein, C ;
Sleight, AJ .
MOLECULAR PHARMACOLOGY, 1997, 52 (03) :515-523
[5]   Amino acids of the alpha(1B)-adrenergic receptor involved in agonist binding: Differences in docking catecholamines to receptor subtypes [J].
Cavalli, A ;
Fanelli, F ;
Taddei, C ;
DeBenedetti, PG ;
Cotecchia, S .
FEBS LETTERS, 1996, 399 (1-2) :9-13
[6]  
Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924
[7]   BROMOACETYLCHOLINE AS AN AFFINITY LABEL OF ACETYLCHOLINE-RECEPTOR FROM TORPEDO-CALIFORNICA [J].
DAMLE, VN ;
MCLAUGHLIN, M ;
KARLIN, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 84 (04) :845-851
[8]  
GANTZ I, 1992, J BIOL CHEM, V267, P20840
[9]   Agonists induce conformational changes in transmembrane domains III and VI of the beta(2) adrenoceptor [J].
Gether, U ;
Lin, S ;
Ghanouni, P ;
Ballesteros, JA ;
Weinstein, H ;
Kobilka, BK .
EMBO JOURNAL, 1997, 16 (22) :6737-6747
[10]   THE ROLE OF CONSERVED ASPARTATE AND SERINE RESIDUES IN LIGAND-BINDING AND IN FUNCTION OF THE 5-HT(1A) RECEPTOR - A SITE-DIRECTED MUTATION STUDY [J].
HO, BY ;
KARSCHIN, A ;
BRANCHEK, T ;
DAVIDSON, N ;
LESTER, HA .
FEBS LETTERS, 1992, 312 (2-3) :259-262